12 December 2025

New Ag International: SOLASTA Bio announces new peptide patents

“These patent grants represent a paradigm shift in crop protection, demonstrating that nature-inspired peptides can be effectively protected for commercial deployment,” says Shireen Davies, CEO and co-founder of SOLASTA Bio. “The breadth of our trials, from rice in Asia to soft fruit in Europe and the U.S., demonstrates the global applicability of our platform and our ability to address pest challenges across diverse crops and geographies.”

The company recently strengthened its U.S. operations with the appointment of Jansen McDaniel, new field trials manager, who will lead global external trials to support SOLASTA’s R&D pipeline for next-generation peptide-based bioinsecticides. Based in North Carolina, McDaniel brings expertise in trial design, data analysis, and regulatory support for biopesticide development. Her background includes managing field programs across the U.S. and Latin America, coordinating with CROs, growers, and academic partners.